Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011
Sun, November 20, 2011
Fri, November 18, 2011
Thu, November 17, 2011
Wed, November 16, 2011

SurModics to Attend Piper Jaffrayas 23rd Annual Health Care Conference on November 29


//health-fitness.news-articles.net/content/2011/ .. nnual-health-care-conference-on-november-29.html
Published in Health and Fitness on Tuesday, November 22nd 2011 at 13:14 GMT by Market Wire   Print publication without navigation


EDEN PRAIRIE, Minn.--([ ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification technologies to the healthcare industry, announced today that it will participate in Piper Jaffrayas 23rd Annual Healthcare Conference in New York City on Tuesday, November 29, 2011. Gary Maharaj, SurModicsa President and Chief Executive Officer, and Timothy Arens, Vice President of Finance and interim Chief Financial Officer, will discuss the Companyas strategy and business conditions during a formal presentation beginning at 9:10 am EST.

The presentation will be available via webcast by visiting the investor relations portion of the Company's website at [ www.surmodics.com ] on the day of the Conference and clicking the webcast icon. In addition, the Conference audio and slide presentation will be archived on the Company's website following the meeting.

About SurModics, Inc.

SurModicsa vision is to extend and improve the lives of patients through technology innovation. The Company partners with the worldas foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModicsa website is not part of this release or part of any filings the Company makes with the SEC.


Publication Contributing Sources